CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Semi‑ and Fully Implantable Middle Ear Hearing Aids — Coverage Criteria

This policy governs coverage determinations for semi‑implantable and fully implantable middle ear hearing aids for adult patients, specifying Medicare Advantage and commercial plan stances and related coding guidance.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicySemi‑ and Fully Implantable Middle Ear Hearing Aids — Coverage Criteria

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionVerify member benefits and eligibility with the provider call center before submission.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

2FDA‑approved semi‑implantable device families

1FDA‑approved fully implantable device

S2230,V5095Not covered codes

Medicare & CommercialPlan types noted

Ch.16CMS manual referenced

Coverage Determinations

Not covered / Not medically necessary

Covered when ALL of the following are met:

Overall coverage stance: Semi‑implantable and fully implantable middle ear hearing aids are not covered for Medicare Advantage and are considered not medically necessary for Commercial Products because the evidence is insufficient to determine effects on health outcomes.

Re‑insertion of the device after removal is specifically not covered (Medicare Advantage) and is considered not medically necessary (Commercial).

Re‑insertion of a semi‑ or fully implantable middle ear hearing device after removal is explicitly excluded for Medicare Advantage members: not covered. For Commercial products, re‑insertion of the device after removal is stated as considered not medically necessary.

General exclusions from coverage referenced in this policy include those found in the CMS Medicare Policy Benefit Manual, Chapter 16. Providers and reviewers should apply those general exclusion rules where relevant to individual coverage determinations.

For Commercial products, semi‑implantable and fully implantable middle ear hearing aids are considered not medically necessary because the evidence is insufficient to determine their effects on health outcomes. This stance applies to the devices and related procedures described in the policy.

Services determined to be not medically necessary or otherwise non‑covered may be denied. If a service is denied or is a non‑covered benefit, the member generally must not be charged unless the provider has informed the member in advance and obtained written agreement that the member will pay at their own expense. Verify member benefit terms and provider participation agreements for specific financial responsibility rules.

Coding and Billing

Not covered / Not medically necessary codesHCPCSNot Covered

S2230	Implantation of magnetic component of semi-implantable hearing device on ossicles in middle ear
V5095	Semi-implantable middle ear hearing prosthesis

Provider Requirements and Actions

Prior Authorization

Prior Authorization / Verify Benefits

Prior authorization: Contact the provider call center for member-specific determinations. Providers should verify member eligibility and benefits prior to delivering services; benefits and coverage may vary by contract and the member's Evidence of Coverage or Benefit Booklet governs benefit limits and exclusions.

Verify eligibility and benefits with the provider call center before scheduling or performing services.
Confirm whether prior authorization is required for the member's plan through the provider call center.

Denial Risk

Coverage and Denial Risk

Claims for semi-implantable and fully implantable middle ear hearing aids may be denied or considered not medically necessary depending on plan coverage. If services are determined to be not covered or not medically necessary, the provider may not charge the member unless the member was informed in writing and agreed to pay out-of-pocket in advance.

Clinical Background

Hearing loss is classified as conductive, sensorineural, or mixed, and may be unilateral or bilateral. Severity is commonly described by pure‑tone average thresholds ranging from mild to profound. Conventional external air‑conduction hearing aids typically treat sensorineural loss, while acoustic or bone‑conduction devices are used for conductive losses; implantable middle ear devices were developed as alternatives when external amplification is unsuitable. Evidence for semi‑ and fully implantable middle ear hearing aids remains insufficient to establish improved health outcomes, which underlies the policy's non‑coverage and not‑medically‑necessary determinations.

Device Definitions

Semi‑implantable middle ear hearing aid — implanted magnetic component (floating mass transducer) description

DefinitionDevice with an implanted magnetic component (floating mass transducer) coupled to middle ear ossicles plus an external receiver and sound processor; the implanted magnetic component vibrates the ossicles via an alternating electromagnetic field.

Typical componentsImplanted magnetic (floating mass transducer) on the ossicles, a subcutaneous receiver, and an external sound processor held by a magnet or positioned in the ear canal (examples: Vibrant Soundbridge, Maxum).

FDA status / indicationsTwo semi-implantable devices have FDA approval (Vibrant Soundbridge and Maxum) intended for adults 18 years and older with moderate to severe sensorineural hearing loss who desire an alternative to acoustic hearing aids.

Fully implantable middle ear hearing aid — implanted sensor, processor, and driver that transduce tympanic membrane vibrations

DefinitionDevice with entirely implanted sensor, sound processor, and driver that transduce tympanic membrane vibrations to the ossicles using piezoelectric transduction, with no external processor required.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicySemi‑ and Fully Implantable Middle Ear Hearing Aids — Coverage Criteria

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionVerify member benefits and eligibility with the provider call center before submission.

SourceLink

On This Page

Services may be denied for Medicare Advantage and commercial products per policy coding and medical necessity determinations.
Refer to the subscriber agreement, member certificate, or employer agreement for member financial responsibility and plan-specific rules.

Note

Benefit Booklet Reference

Refer to the member's Benefit Booklet / Evidence of Coverage or Subscriber Agreement for group/contract-specific benefit limits and coverage details.

Benefit Booklet/Evidence of Coverage determines coverage when services are non-covered or not medically necessary.

Typical componentsImplanted sensor (placed at the head of the incus), implanted sound processor, and implanted driver (delivers signals to the stapes) using piezoelectric transducers (example: Esteem Implantable Hearing System).

FDA status / indicationsOne fully implantable middle ear hearing aid (Esteem) has FDA premarket approval for adults 18 years and older with stable bilateral sensorineural hearing loss.

Active middle ear implant — examples and description (Vibrant Soundbridge, Esteem, Envoy, Carina)

Definition / functionActive middle ear implants are implantable hearing devices that mechanically stimulate middle ear structures (ossicles or round window) to improve hearing in conductive, mixed, or sensorineural loss.

Named examplesVibrant Soundbridge (MED-EL), Esteem (Envoy), Envoy System, and Carina (in development).

Transduction methodsSemi-implantable devices use electromagnetic transduction via a floating mass transducer; fully implantable devices (e.g., Esteem) use piezoelectric transduction with implanted sensor and driver.

Regulatory / development statusVibrant Soundbridge and Maxum have FDA approval; Esteem received FDA premarket approval; Carina has been investigated but does not have FDA approval.